New faces at the top for Glos medical product manufacturer

Photo shows: Chris Lee
Summit Medical Chris Lee Hi res

Bourton-on-the-Water based medical product manufacturer, Summit Medical Group,  has appointed a new CEO and Chief Commercial Officer

Chris Lee has been appointed Chief Executive Officer, with Steve Brewster as Chief Commercial Officer.

Chris joined Summit Medical having enjoyed a successful career in the medical device industry including an 18 year career at Johnson & Johnson where he became President, EMEA of the Ethicon Franchise with revenues of $1billion and a direct team of 300 people. During his tenure at Johnson & Johnson, Chris was also responsible for the Global DePuy Trauma, Extremities and Biologics business based out of DePuy’s headquarters in the US.

Most recently, Chris held the position of CEO for Venner Medical International based in Jersey; an organisation working directly with clinician inventors to take innovative technologies from ideas through to commercialisation.

Steve Brewster joins the organisation as Chief Commercial Officer; most recently having held the position of Director, Europe Middle East & Africa – Lower Extremities & Trauma for Zimmer Biomet. Steve was also a member of the Zimmer Biomet Global Extremities Mergers and Acquisitions Team

Following the sale of his agency to Zimmer at the end of 2015, Steve previously held the position of Sales and Marketing Director for Zimmer’s UK organisation. Leading an extended team of 75, his focus was on creating a strong inclusive culture ensuring positive business turnaround after a number of challenging years for growth.

Oern Stuge, Chairman of the Summit Medical Board, said: “We are delighted Chris and Steve have chosen to join the business and by using their vast experience, leadership skills and strong emphasis on a positive culture we are excited about the future for Summit Medical Group and its customers.”

Summit Medical was founded in 1984. Employing more than 100 people, it manufactures and sells medical devices which it now distributes to more than 40 countries worldwide.

In its last published accounts, Turnover for the year in 2019 was £14.6 million, an increase of 6.6 per cent on the previous year. Summit Medical invested close to £1 million in research and development.